Fig. 3
From: Toll-like receptor 9 negatively related to clinical outcome of AML patients
The median TLR9 in regard to the risk estimated by cytogenetic analysis of the studied AML patients
Fig. 3 | Journal of the Egyptian National Cancer Institute